Global Health Ltd share price target is in sharp focus as Medanta (NSE: MEDANTA) shows a powerful technical breakout and approaches its all-time high. Investors want to know: can the share sustain its momentum and set new records in 2026? Let’s dive into the technical and fundamental analysis.

Part 1: Technical Analysis

Chart Overview:
The attached chart for Global Health Ltd (NSE: MEDANTA) clearly illustrates a strong breakout above resistance, with the price reaching new all-time highs around ₹1,456.

• Breakout Confirmation:
  After a lengthy consolidation phase, Medanta’s share has pierced key resistance levels, reaching its lifetime high accompanied by a sharp surge in trading volumes (see the green volume bars at the breakout point). Such volume is often viewed as confirmation of genuine institutional buying.

• Support and Momentum Indicators:
  The red line is the 200-day EMA (a major long-term support), and the green line is the AVWAP (anchored volume weighted average price) from April 2023. Medanta’s price has been trending well above both, suggesting sustained bullish sentiment.

  • The recent consistent closes above the 200 EMA and AVWAP confirm the uptrend’s strength.

• Yearly Share Price Target Estimate:
  Based on this breakout, ongoing momentum, and volume confirmation, Medanta could potentially target ₹1,750–₹1,800 in the coming year, assuming market sentiment and company fundamentals remain positive.

• Key Risk Levels:
  If price falls back below ₹1,400 (a now-critical support) or the 200 EMA, it may signal short-term consolidation or trend reversal.

Part 2: Fundamental Analysis

About Global Health Ltd (Medanta):
Global Health Ltd is among India’s largest private multi-specialty tertiary care hospital chains, best known under the Medanta brand. It operates five major hospitals across Gurugram, Indore, Ranchi, Lucknow, and Patna, with new facilities under development in Noida, Mumbai, Pitampura (Delhi), and South Delhi.

Business Highlights

• Bed Capacity and Expansion:

  • Currently hosts 3,008 beds across strategic locations; Noida (550 beds) coming up in FY26, Mumbai (>500 beds planned), and Pitampura (~750 beds pending approval).

  • Major capex plans of ₹2,800Cr to add 2,900+ beds over next 5 years.

• Clinical Leadership:

  • 1,750+ doctors, 6,800+ nurses, and 30+ medical specialties—leaders in cardiac, neuro, oncology, digestive sciences, and transplants.

  • Top international hospital rankings for Gurugram facility (Newsweek).

• Revenue Segmentation (Q2FY25):

  • Heart (21%), Cancer (14%), Digestive (12%), Neuro (12%), Kidney/Urology (8%), Internal Medicine (7%), Ortho (4%), Liver Transplant (3%), Others (20%).

• Operational Efficiency:

  • Q2FY24 metrics show 61.6% occupancy, ARPOB (Average Revenue Per Occupied Bed) of ₹63,023, and nearly 1.5 lakh outpatient visits.

• Technological Edge:

  • Deploying advanced MRIs, robotic surgical systems, and high-dose radiopharma.

  • Clinics expanding preventive, diagnostic, and daycare services.

• International Recognition:

  • 6% of H1FY25 revenue from international patients—Medanta is a destination for medical tourism.

Financial Snapshot (August 2025)

 

Growth

• Net Profit (Last 5 Years, ₹Cr): 29, 196, 326, 478, 481

• Sales Growth:

  • 5-year CAGR: 20%

  • 3 years: 19%

  • TTM: 15%

• Profit Growth:

  • 5-year CAGR: 70%

  • 3 years: 38%

  • TTM: 18%

Key Strengths

• Market leader with doctor-driven management ensuring best-in-class medical care.

• Aggressive expansion & capex for capacity increases in key metro locations.

• International recognition and growing medical tourism revenues.

• Robust profitability & earnings growth, with nearly 70% CAGR in net profit over five years.

• Strong reserves and manageable debt, supporting capex without significant financial risk.

Conclusion: Yearly Share Price Target & Outlook

The combination of a strong technical breakout above resistance and rapid, profitable expansion positions Global Health Ltd (Medanta) as one of the most promising hospital sector stocks in India. If current trends hold and execution is successful, a yearly share price target in the ₹1,750–₹1,800 range appears attainable.

Investors should monitor:

• Volume, price action above support, and new hospital project execution.

• Quarterly earnings and any regulatory news affecting expansion.

• The Global Health Ltd share price target for 2026 will depend on the stock’s ability to maintain this breakout zone above ₹1,450
• Based on current technical and business expansion trends, Global Health Ltd share price target could reach ₹1,750–1,800 in the coming year.

Check Kajaria Ceramics share analysis : here

More more info visit: here